Patent · US Active

Fluorescence-based assay for the rapid detection and quantification of deoxyribonucleoside triphosphates

US8815509B2 · kind B2 · utility

0Cited by
1References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 14, 2012
Grant dateAug 26, 2014
Priority date
Expiry dateJun 14, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N21/6428
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The inventors have developed a rapid and sensitive fluorescence-based assay to quantify dNTPs. This assay relies on the principle that incorporation of a limiting dNTP is required for primer-extension and polymerase-mediated 5-3′ exonuclease hydrolysis of a quenched fluorophore-labeled probe resulting in fluorescence. The concentration of limiting dNTPs is directly proportional to the fluorescence generated. This assay has important applications in research that investigates the influence of pathological conditions or pharmacological agents on dNTP biosynthesis and regulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.